Could we use a lower dose of rituximab to treat rheumatoid arthritis in clinical practice: pros and cons?
The CERERRA database provides evidence that low-dose rituximab performs as well as the conventional dose in the real world, thus highlighting the possible pharmacoeconomic impact. In clinical trials, it has be...
Source: Arthritis Research and Therapy - Category: Rheumatology Authors: Gianfranco Ferraccioli, Barbara Tolusso and Elisa Gremese Source Type: research
More News: Arthritis | Clinical Trials | Databases & Libraries | Rheumatoid Arthritis | Rheumatology | Rituxan